WARRINGTON, Pa., Dec. 9, 2019 /PRNewswire/ — Windtree Therapeutics, Inc. (OTCQB: WINT), a biotechnology and medical device company focused on developing drug product candidates and medical device technologies to address acute cardiovascular and pulmonary diseases, today announced that it has completed a $26.4 million private placement of common stock and warrants. In connection with this offering, […]
Other News
QuVa Pharma® Launches Cardioplegia Offering through a Compounding and Distribution Agreement with Hibernation Therapeutics for Adenocaine™ Solution
Access to improved Adenocaine™ solution, a ready to administer heart arrest and cardioprotection innovation, is immediately available to hospitals nationwide SUGAR LAND, Texas, Dec. 9, 2019 /PRNewswire/ — QuVa Pharma, Inc. today announced it has signed a production and distribution agreement with Hibernation Therapeutics for its patented cardioplegia solution Adenocaine™, the combination of […]
BioVentrix Announces Publication of Positive One-Year Outcomes for Revivent TC System
Study Published in European Journal of Heart Failure Shows Significant and Sustained Improvement in Heart Function, Symptom Relief and Quality of Life Using Less Invasive Left Ventricular Enhancement Device SAN RAMON, Calif.–(BUSINESS WIRE)–BioVentrix, Inc., developer of the first less invasive system for left ventricular remodeling, today announced online publication of positive […]
InnovHeart Appoints Brent Ratz as Independent member of the board
MILAN, Dec. 5, 2019 /PRNewswire/ — InnovHeart s.r.l., a developer of novel transcatheter mitral valve replacement (TMVR) systems for the treatment of patients with mitral valve disease, announces the appointment of experienced medical device entrepreneur, Mr. J. Brent Ratz, as non-executive independent member of its Board of Directors. Mr. Ratz has over 19 years […]
Edwards Lifesciences Outlines Growth Strategy At Annual Investor Conference
NEW YORK, Dec. 5, 2019 /PRNewswire/ — Edwards Lifesciences Corporation (NYSE: EW), the global leader in patient-focused innovations for structural heart disease and critical care monitoring, will discuss the company’s strategy for longer-term growth, provide an update on its technology pipeline and share its financial guidance during its annual investor conference today in New […]
TransMedics’ Organ Care System (OCS™) Technology Used in First U.S. Adult Human Heart Transplants From DCD Donors
ANDOVER, Mass., Dec. 04, 2019 (GLOBE NEWSWIRE) — TransMedics Group, Inc. (“TransMedics”) (Nasdaq: TMDX), a medical technology company that is transforming organ transplant therapy for patients with end-stage lung, heart and liver failure, today announced the completion of the first successful adult human heart transplants from DCD (donation after circulatory […]
AtriCure Names Two Industry Veterans to Board of Directors
MASON, Ohio–(BUSINESS WIRE)–AtriCure, Inc. (Nasdaq: ATRC), a leading innovator in treatments for atrial fibrillation (Afib) and left atrial appendage (LAA) management, today announced that Karen Prange and Daniel Florin have been named to its Board of Directors. Ms. Prange was most recently Executive Vice President and Chief Executive Officer for the Global […]
Canon Medical’s Alphenix Platform at the Forefront of Helping Hospitals Prepare for the Future of Interventional Medicine
Canon Medical to Showcase High-Definition Image Resolution Technology at RSNA 2019 CHICAGO–(BUSINESS WIRE)–Since its launch in 2018, Canon Medical’s Alphenix™ platform has helped clinicians think beyond the traditional boundaries of interventional procedures, with its streamlined workflow, dose optimization and improved image resolutions. For example, the specialized team of neuroendovascular surgeons […]
Neovasc Named Finalist in Questex’s Fierce Innovation Awards LifeSciences Edition 2019
VANCOUVER, Dec. 04, 2019 (GLOBE NEWSWIRE) — via NEWMEDIAWIRE — Neovasc, Inc. (“Neovasc” or the “Company”) (NASDAQ, TSX: NVCN): NVCN), a leader in the development of minimally invasive transcatheter mitral valve replacement technologies and in the development of minimally invasive devices for the treatment of refractory angina, announced today that it has been […]
Biotricity Completes Development of its ECG Patch Platform
Company Prepares for FDA Filing of New Device REDWOOD CITY, Calif., Dec. 04, 2019 (GLOBE NEWSWIRE) — Biotricity Inc. (OTCQB: BTCY), a medical diagnostic and consumer healthcare technology company, today announced that it has completed development of its ECG patch platform. An extension of the company’s award-winning Bioflux® device, Biopatch is ideal for patients with less […]
Recent
Efemoral Medical Reports Exceptional Long-Term EFEMORAL I Results Highlighting Durability and Differentiated Performance in Femoropopliteal Disease
Xeltis releases groundbreaking new 12-month EU pivotal data for aXess™ demonstrating the transformative potential in hemodialysis treatment
First Peer-Reviewed Study to Evaluate AI-Generated Impressions Demonstrates Radiologist Preference for Domain-Specific Versus General Models
Popular
- No commented posts yet